Saccharin: a Lead Compound for Structure-Based Drug Design of Carbonic Anhydrase IX Inhibitors

Carbonic anhydrase IX (CA IX) is a key modulator of aggressive tumor behavior and a prognostic marker and target for several cancers. Saccharin (SAC) based compounds may provide an avenue to overcome CA isoform specificity, as they display both nanomolar affinity and preferential binding, for CA IX...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bioorg Med Chem
Autores principales: Mahon, Brian P., Hendon, Alex M., Driscoll, Jenna M., Rankin, Gregory M., Poulsen, Sally-Ann, Supuran, Claudiu T., McKenna, Robert
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352949/
https://ncbi.nlm.nih.gov/pubmed/25614109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2014.12.030
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares